antimicrobi
resist
import
concern
anim
health
antimicrobi
treatment
caus
select
pressur
trigger
select
resist
bacteria
select
persist
spread
strain
within
popul
often
puzzl
lead
failur
usual
treatment
infect
moreov
administr
antimicrobi
agent
use
human
medicin
product
anim
fluoroquinolon
could
lead
emerg
public
health
issu
due
persist
dissemin
resist
bacteria
although
surveil
resist
zoonot
bacteria
direct
implic
public
health
polici
monitor
bacteria
commens
flora
escherichia
coli
strain
remain
good
indic
resist
pattern
within
popul
knowledg
resist
pattern
commens
bacteria
pivot
risk
transmiss
resist
gene
nonpathogen
zoonot
bacteria
quinolon
wide
use
pig
product
mainli
control
urinari
tract
infect
sow
belloc
et
al
observ
quinolon
treatment
caus
strong
select
pressur
e
coli
popul
treat
sow
piglet
studi
treatment
routin
administ
pregnant
sow
around
farrowingtim
even
though
effect
transitori
faecal
flora
piglet
clearli
modifi
treatment
dam
lead
dramat
increas
withinhost
proport
resist
e
coli
longterm
impact
routin
practic
antimicrobi
use
unknown
enrich
resist
flora
durat
use
highli
suspect
studi
long
term
ecolog
evolut
within
popul
requir
mathemat
model
approach
date
epidemiolog
model
develop
studi
spread
infecti
agent
within
pigproduct
unit
best
knowledg
one
model
approach
focuss
impact
antimicrobi
consumpt
emerg
andor
transmiss
resist
strain
within
finish
pig
herd
studi
highlight
need
model
framework
incorpor
current
knowledg
epidemiolog
antimicrobi
resist
anim
key
factor
use
character
withinherd
dynam
resist
bacteria
influenc
antimicrobi
pressur
knowledg
transmiss
dynam
resist
bacteria
would
improv
understand
influenc
onsit
farm
practic
drug
usag
infect
control
dynam
resist
bacteria
anim
could
also
form
basi
releas
assess
compon
risk
assess
abatih
et
al
use
determinist
si
susceptibleinfectioussuscept
model
infecti
individu
divid
two
subgroup
ii
ir
accord
level
suscept
antimicrobi
agent
author
conclud
persist
resist
bacteria
within
finish
strongli
relat
transmiss
paramet
valu
transmiss
rate
key
paramet
epidemiolog
model
howev
estim
paramet
often
present
challeng
sinc
mani
infecti
diseas
onset
clinic
symptom
final
outcom
diseas
observ
field
condit
experiment
transmiss
trial
provid
use
tool
assess
infect
dynam
control
environ
differ
estim
method
use
analys
result
transmiss
experi
maximum
likelihood
estim
mle
generalis
linear
model
glm
becker
martingal
formula
base
final
size
epidem
aim
studi
quantifi
transmiss
pathogen
infecti
agent
viral
bacteri
howev
best
knowledg
none
experiment
studi
focuss
transmiss
resist
bacteri
strain
aim
present
work
studi
horizont
transmiss
fluoroquinoloneresist
e
coli
strain
pig
purpos
transmiss
experi
carri
focuss
transmiss
vitro
select
e
coli
inocul
specif
pathogen
free
spf
piglet
transmiss
paramet
estim
appli
maximum
likelihood
method
account
differ
transmiss
level
relat
amount
resist
bacteria
recov
individu
faec
infect
anim
experi
conduct
airfilt
level
biosecurityfacil
five
independ
room
use
one
two
pen
per
room
figur
pig
hous
flat
deck
fulli
slat
floor
one
metr
floor
facil
sixtyfour
largewhit
spf
pig
age
seven
week
begin
experi
use
studi
anim
wean
three
week
experi
receiv
nonsuppl
feed
antimicrobi
treatment
administ
either
start
cours
experi
six
pig
kept
neg
control
posit
inocul
control
remain
pig
randomli
assign
group
pig
inocul
spf
pig
group
pig
inocul
spf
pig
group
conduct
separ
betweengroup
transmiss
avoid
solid
partit
pen
inocul
perform
oral
success
administ
ml
bacteri
suspens
cfuml
day
prior
contact
spf
pig
contactday
contact
instig
mix
inocul
pig
four
hour
second
inocul
bacteri
suspens
consist
ciprofloxacinresist
e
coli
vitro
select
faecal
flora
fulli
suscept
e
coli
strain
isol
specif
pathogen
free
spf
pig
herd
select
e
coli
chromosom
mutat
perform
spread
larg
amount
inoculum
cfu
onto
plate
supplement
increas
concentr
ciprofloxacin
sigmafluka
stquentinfallavi
franc
minimum
inhibitori
concentr
ciprofloxacin
select
resist
strain
mgl
etest
franc
suspens
administ
use
soft
steril
cathet
gentli
deepli
introduc
oesophagu
prevent
inoculum
flow
back
contamin
environ
pig
monitor
daili
take
faecal
sampl
day
preced
inocul
day
postinocul
everi
day
day
clinic
sign
also
record
daili
pig
weigh
week
bacteri
count
measur
g
faec
use
serial
dilut
one
hundr
microlit
dilut
plate
chromogen
agar
chromocult
agar
es
merckvwr
strasbourg
franc
supplement
mgl
ciprofloxacin
sigmafluka
stquentinfallavi
franc
plate
incub
h
coloni
count
method
allow
quantif
concentr
inocul
e
coli
greater
equal
cfug
faec
experi
end
two
week
inocul
euthanasia
carri
anaesthesia
intraven
inject
kg
liveweight
merial
lyon
franc
follow
exsanguin
follow
organ
examin
macroscop
immedi
kill
lung
tonsil
heart
kidney
thymu
lymph
node
inguin
mesenter
tracheobronchi
differ
part
digest
tract
oesophagu
stomach
duodenum
jejunum
ileum
colon
caecum
macroscop
lesion
suspect
sampl
taken
tissu
histopatholog
examin
experi
perform
accord
eu
french
regul
anim
welfar
experiment
protocol
approv
afssaenvaupec
ethic
committe
analysi
varianc
use
compar
bacteri
count
accord
anim
statu
contact
inocul
pig
group
size
pig
per
pen
comparison
perform
bacteriolog
result
obtain
start
end
experi
lm
function
r
softwar
base
bacteriolog
result
stochast
si
susceptibleinfectioussuscept
model
use
estim
transmiss
paramet
classic
sir
susceptibleinfectiousremov
model
rate
suscept
anim
infect
given
transmiss
paramet
defin
mean
number
new
infect
caus
typic
infecti
individu
per
unit
time
n
repres
number
infecti
total
number
individu
respect
pig
classifi
suscept
infecti
accord
quantiti
resist
bacteria
record
individu
faecal
sampl
chang
individu
statu
observ
two
sampl
date
either
suscept
infecti
reciproc
consid
occur
midtim
interv
individu
consid
suscept
quantiti
fluoroquinoloneresist
e
coli
threshold
level
fix
cfug
accord
literatur
data
individu
bacteri
count
threshold
quantiti
consid
infecti
ie
consid
abl
transmit
resist
bacteria
suscept
pig
three
hypothes
propos
regard
abil
infecti
anim
transmit
resist
bacteria
suscept
one
depend
amount
resist
bacteria
individu
faecal
sampl
equal
transmiss
rate
shed
pig
bacteri
count
threshold
valu
cfug
two
transmiss
level
accord
bacteri
count
pig
shed
cfug
resist
e
coli
consid
low
shedder
il
compar
pig
shed
cfug
faec
ih
three
transmiss
level
accord
bacteri
count
intermedi
shed
level
includ
pig
shed
cfug
resist
e
coli
consid
low
shedder
il
bacteri
count
rang
cfug
pig
classifi
moder
shedder
im
wherea
high
shedder
hypothesi
bacteri
count
exceed
cfug
ih
hypothes
led
differ
model
increas
complex
could
use
studi
relationship
shed
pattern
transmiss
potenti
infecti
pig
howev
model
obtain
third
hypothesi
could
consid
full
model
three
transmiss
paramet
second
hypothesi
simplif
model
first
hypothesi
deriv
latter
assign
equal
valu
transmiss
paramet
maximum
likelihood
method
base
stochast
si
susceptibleinfectioussuscept
model
use
estim
transmiss
paramet
follow
model
probabl
q
singl
suscept
pig
escap
infect
time
interv
equal
q
exp
repres
transmiss
level
infecti
pig
l
h
low
moder
highshedd
equat
proport
infecti
anim
shed
class
correspond
transmiss
paramet
p
q
probabl
suscept
individu
infect
number
new
infect
follow
binomi
distribut
c
bin
p
number
suscept
anim
contact
loglikelihood
binomi
distribut
log
l
cjlog
exp
dj
sjdj
sj
cj
number
suscept
anim
case
sampl
interv
j
respect
dj
durat
interv
two
sampl
time
log
sjcj
omit
play
role
calcul
differ
paramet
estim
use
maxim
loglikelihood
nlm
function
r
softwar
version
confid
interv
determin
use
invers
hessian
matrix
variancecovari
matrix
paramet
estim
also
provid
nlm
function
r
softwar
clinic
sign
observ
experi
daili
weight
gain
dwg
similar
challeng
group
figur
control
pig
individu
contact
group
data
shown
resist
e
coli
isol
either
inocul
pig
contact
group
neg
control
group
throughout
entir
experi
anim
inocul
control
group
posit
resist
bacteri
count
contactday
count
declin
steadili
end
experi
figur
inocul
pig
contact
group
posit
resist
bacteri
count
ie
one
day
first
inocul
individu
bacteri
count
inocul
pig
increas
day
postcontact
rang
cfug
bacteri
count
inocul
pig
decreas
period
day
invers
trend
increas
bacteri
count
observ
inocul
pig
day
day
postcontact
probabl
due
infecti
pressur
exert
contamin
contact
pig
tendenc
observ
inocul
control
group
similar
pattern
observ
contact
group
lag
day
nineteen
contact
pig
posit
bacteri
count
day
postcontact
pig
contact
group
found
posit
day
postcontact
overal
decreas
bacteri
count
observ
day
postcontact
similar
transmiss
behaviour
observ
pen
signific
differ
found
individu
bacteri
count
accord
number
pig
per
pen
trial
involv
inocul
pig
respect
contact
pig
either
inocul
contact
pig
tabl
equival
bacteri
count
record
day
postcontact
inocul
contact
group
p
figur
experi
resist
bacteri
count
least
one
sampl
contact
inocul
pig
detect
limit
method
resist
strain
could
detect
three
pig
inocul
pig
bacteri
count
cfug
highshedd
still
show
high
shed
level
day
postcontact
moder
shed
level
cfug
found
transient
phase
low
highshed
transmiss
paramet
differ
accord
assumpt
made
shed
pattern
tabl
three
model
nest
akaik
inform
criterion
aic
appli
model
select
aic
valu
close
whatev
underli
hypothesi
lowest
aic
obtain
second
hypothesi
aic
two
transmiss
rate
consid
estim
transmiss
lowshedd
model
time
less
effici
highshedd
estim
modifi
introduc
intermedi
transmiss
level
correspond
pig
shed
less
cfug
close
estim
larger
confid
interv
due
limit
number
anim
class
aim
studi
assess
horizont
transmiss
fluoroquinoloneresist
e
coli
within
swine
popul
although
emerg
select
antimicrobialresist
link
antimicrobi
consumpt
transmiss
resist
bacteria
individu
could
pivot
factor
govern
persist
within
pig
herd
transmiss
may
occur
swine
herd
mix
pig
treat
litter
deriv
treat
nontreat
sow
observ
paramet
estim
avail
passiv
horizont
transmiss
resist
commens
bacteria
anim
experiment
trial
design
studi
transmiss
fluoroquinoloneresist
e
coli
inocul
pig
absenc
select
pressur
studi
natur
infect
use
contact
anim
rather
artifici
inocul
anim
presum
higher
infecti
recommend
start
infect
chain
studi
artifici
inocul
pig
use
present
experi
order
limit
number
pig
involv
howev
amount
resist
bacteria
shed
inocul
pig
day
contact
within
rang
observ
treat
anim
piglet
born
treat
sow
addit
signific
differ
found
amount
bacteria
shed
inocul
contact
pig
present
result
therefor
consid
realist
repres
transmiss
pattern
occur
field
condit
moreov
date
plasmidmedi
quinolon
resist
report
e
coli
isol
pig
franc
observ
consid
consist
current
epidemiolog
onfarm
situat
experiment
design
develop
mimic
situat
found
field
condit
repres
mix
piglet
differ
litter
heterogen
resist
pattern
suggest
kroes
de
jong
number
inocul
contact
pig
equival
experiment
trial
slightli
fewer
inocul
pig
pen
inocul
versu
contact
anim
affect
transmiss
effect
contact
pig
posit
count
fluoroquinoloneresist
e
coli
two
day
contact
demonstr
strong
infecti
pressur
exert
inocul
anim
declin
bacteri
count
faec
inocul
pig
overal
increas
observ
day
end
experi
result
evidenc
possibl
reinfect
inocul
pig
newli
contamin
anim
assumpt
also
support
fact
control
inocul
pig
mix
anim
exhibit
behaviour
ie
bacteri
count
declin
steadili
day
end
experi
reinfect
could
favour
withingroup
persist
resist
bacteria
maximum
likelihood
method
use
paramet
estim
took
account
timecours
transmiss
process
reinfect
inocul
anim
preclud
use
algorithm
final
size
algorithm
well
individu
bacteri
count
threshold
transmiss
level
cfug
fix
accord
literatur
data
addit
specif
transmiss
experi
would
need
establish
infecti
dose
resist
e
coli
strain
howev
method
use
present
studi
base
classic
hypothes
sir
epidemiolog
model
account
horizont
transmiss
individu
role
environment
airborn
transmiss
consid
would
need
investig
three
sheddinglevel
consid
present
studi
result
nest
model
allow
heterogen
transmiss
rate
transmiss
lowshedd
inde
time
less
effici
highshedd
role
variat
individu
infecti
cours
infect
highlight
sever
studi
inde
transmiss
rate
could
influenc
sever
factor
timesinceinfect
individu
bacteri
count
role
superspread
clearli
identifi
differ
infecti
agent
eg
mrsa
e
coli
salmonella
transmiss
rate
found
relat
individu
bacteri
count
model
dynam
drugresist
bacteria
within
pig
herd
would
requir
repres
withinhost
dynam
bacteri
popul
account
differ
suscept
level
model
approach
take
account
resist
mechan
bacteria
target
antibacteri
agent
plasmid
chromosom
gene
impact
select
pressur
exert
antimicrobi
exposur
end
withinhost
bacteri
popul
model
account
pharmacokineticpharmacodynam
aspect
could
coupl
epidemiolog
model
repres
spread
resist
within
popul
model
would
allow
identif
key
manag
treatment
strategi
could
limit
prevent
spread
resist
strain
individu
present
studi
focuss
transmiss
e
coli
strain
harbour
chromosom
resist
fluoroquinolon
could
cornerston
develop
pharmacoepidemiolog
model
author
declar
compet
interest
analys
data
draft
manuscript
alr
ej
perform
bacteriolog
studi
rc
supervis
experi
ej
nr
ps
ml
cc
conceiv
studi
particip
design
coordin
author
read
approv
final
manuscript
